Solvay


Unchanged pattern in Q4

13/01/21 -"The last quarter of the challenging pandemic-hit 2020 seems to have shown a continuation of the stabilisation but it is seen below the previous year's level. This had not been expected from our side. ..."

Pages
59
Language
English
Published on
13/01/21
You may also be interested by these reports :
17/10/25
Yara’s Q3 2025 results were mixed, with sales slightly below (1.8%) and EBITDA above (2.7%) market estimates – the latter supported by lower input ...

16/10/25
The change in the target price is due to a change in the analyst covering the stock, complemented by the usage of systematic intrinsic and peer-based ...

07/10/25
The improvement in our target has primarily been driven by the increase in earnings. In particular, the peer valuation has been impacted by our new ...

30/09/25
The improvement in our target is primarily driven by the increase in earnings. The peer valuation has been especially impacted due to our new ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO